Rahul Pawara

Shirpur, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Structural Exploration of Pyrazine-1,2,3-Triazole Hybrids as Selective Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.

Structural Exploration of Pyrazine-1,2,3-Triazole Hybrids as Selective Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.

Journal: Drug development research

Published: December 28, 2025

Optimizing cardio, hepato and phospholipidosis toxicity of the Bedaquiline by chemoinformatics and molecular modelling approach.

Optimizing cardio, hepato and phospholipidosis toxicity of the Bedaquiline by chemoinformatics and molecular modelling approach.

Journal: SAR and QSAR in environmental research

Published: February 28, 2022

Emerging Approaches to Overcome Acquired Drug Resistance Obstacles to Osimertinib in Non-Small-Cell Lung Cancer.

Emerging Approaches to Overcome Acquired Drug Resistance Obstacles to Osimertinib in Non-Small-Cell Lung Cancer.

Journal: Journal of medicinal chemistry

Published: July 29, 2021

Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M Non-Small-Cell lung cancer (NSCLC).

Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M Non-Small-Cell lung cancer (NSCLC).

Journal: Bioorganic chemistry

Published: June 01, 2021

Computational identification of 2,4-disubstituted amino-pyrimidines as L858R/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation, DFT study and molecular dynamic simulation.

Computational identification of 2,4-disubstituted amino-pyrimidines as L858R/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation, DFT study and molecular dynamic simulation.

Journal: In silico pharmacology

Published: April 29, 2021

The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19.

The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19.

Journal: Topics in current chemistry (Cham)

Published: December 20, 2020

Corrigendum to "Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors" [Eur. J. Med. Chem. 167 (2019) 1-9].

Corrigendum to "Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors" [Eur. J. Med. Chem. 167 (2019) 1-9].

Journal: European journal of medicinal chemistry

Published: June 09, 2020

Investigating the Impact of Different Acrylamide (Electrophilic Warhead) on Osimertinib's Pharmacological Spectrum by Molecular Mechanic and Quantum Mechanic Approach.

Investigating the Impact of Different Acrylamide (Electrophilic Warhead) on Osimertinib's Pharmacological Spectrum by Molecular Mechanic and Quantum Mechanic Approach.

Journal: Combinatorial chemistry & high throughput screening

Published: May 28, 2020

In silico search of triple mutant T790M/C797S allosteric inhibitors to conquer acquired resistance problem in non-small cell lung cancer (NSCLC): a combined approach of structure-based virtual screening and molecular dynamics simulation.

In silico search of triple mutant T790M/C797S allosteric inhibitors to conquer acquired resistance problem in non-small cell lung cancer (NSCLC): a combined approach of structure-based virtual screening and molecular dynamics simulation.

Journal: Journal of biomolecular structure & dynamics

Published: February 28, 2020

A structural insight of bedaquiline for the cardiotoxicity and hepatotoxicity.

A structural insight of bedaquiline for the cardiotoxicity and hepatotoxicity.

Journal: Tuberculosis (Edinburgh, Scotland)

Published: April 15, 2019

Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.

Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.

Journal: European journal of medicinal chemistry

Published: May 14, 2018

Design and synthesis of novel 2,4-disubstituted aminopyrimidines: reversible non-covalent T790M EGFR inhibitors.

Design and synthesis of novel 2,4-disubstituted aminopyrimidines: reversible non-covalent T790M EGFR inhibitors.

Journal: Journal of receptor and signal transduction research

Published: January 01, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026